Navega Therapeutics

San Diego, CA · Founded 2018 · Privately Held (backing)

Developer of gene therapies designed to treat chronic pain and tackle the opioid epidemic. Navega Therapeutics is based in San Diego, CA and was founded in 2018. It has raised $2.4 million across 1 recorded round; the latest was a $1.3 million seed round in Jan 2026.

Last price · $/share
—
Implied valuation
—
Total raised
$2.4M
Last round
Seed Round
Jan 2026

Who backs Navega Therapeutics?

13 investors
InvestorType
Creative Destruction LabOther
National Institutes of HealthOther
University of CaliforniaOther
CONNECT (San Diego)Other
Good VenturesOther
Ad Astra Ventures—
California Institute for Regenerative Medicine—
California Life Sciences—
Institute for the Global Entrepreneur—
National Cancer Institute—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Navega Therapeutics investors

13 investors are on record for Navega Therapeutics, including Creative Destruction Lab, National Institutes of Health, University of California and CONNECT (San Diego). The seed round in Jan 2026 drew 8 investors.

Free account
More of Navega Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch Navega Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Navega Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View